Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Treatment for Pompe Disease
RespireRx Pharmaceuticals Inc., the University of Alberta and the University of Florida Provide Update on Collaborative Research Activities
NextSource Materials Signs Agreement for the Supply of Graphite Fines as Additional Source of Feedstock for its Battery Anode Facility in Abu Dhabi
